The annual proxy for this Chilean chemical and plant nutrients company had the following proposals:
- Ten board proposals
- Nine extraordinary proposals
A US-style proxy document was not available. The only available information regarded competing slates of director candidates. The slates did not provide sufficient information to determine which slate would best represent shareholders. As such, Magni abstained from the election of directors.
The remaining 18 proposals had no supporting information. Conducting shareholder votes where the proposals are not explained is poor governance. As such, Magni voted against the 18 proposals.